137 related articles for article (PubMed ID: 16597538)
1. Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
Soheilian M; Aletaha M; Yazdani S; Dehghan MH; Peyman GA
Ocul Immunol Inflamm; 2006 Apr; 14(2):91-8. PubMed ID: 16597538
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
Shen E; Rathinam SR; Babu M; Kanakath A; Thundikandy R; Lee SM; Browne EN; Porco TC; Acharya NR
Am J Ophthalmol; 2016 Aug; 168():279-286. PubMed ID: 27296490
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada Disease in Pre-school Children.
Sadhu S; Dutta Majumder P; Shah M; George R
Ocul Immunol Inflamm; 2024 May; 32(4):415-418. PubMed ID: 36084279
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
5. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravitreal dexamethasone implant in patients with Vogt-Koyanagi-Harada Disease and bilateral panuveitis: Two case reports.
Chen PL; Chen SN
Medicine (Baltimore); 2021 Oct; 100(40):e27394. PubMed ID: 34622843
[TBL] [Abstract][Full Text] [Related]
7. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
8. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
Urzua CA; Velasquez V; Sabat P; Berger O; Ramirez S; Goecke A; Vásquez DH; Gatica H; Guerrero J
Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265
[TBL] [Abstract][Full Text] [Related]
9. Vogt-Koyanagi-Harada disease in Thailand.
Yodmuang T; Rothova A; Kunavisarut P; Pathanapitoon K
Ocul Immunol Inflamm; 2012 Dec; 20(6):419-22. PubMed ID: 23163754
[TBL] [Abstract][Full Text] [Related]
10. Vogt Koyanagi Harada disease: treatment and visual prognosis.
Alam M; Iqbal M; Khan BS; Hussain I
J Coll Physicians Surg Pak; 2013 Oct; 23(10):740-2. PubMed ID: 24112262
[TBL] [Abstract][Full Text] [Related]
11. A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab.
Su E; Oza VS; Latkany P
J Formos Med Assoc; 2019 May; 118(5):945-950. PubMed ID: 30616991
[TBL] [Abstract][Full Text] [Related]
12. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
Chee SP; Jap A
Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203
[TBL] [Abstract][Full Text] [Related]
13. Corticotherapy vs. Corticotherapy Plus Immunosuppressive Therapy in Acute Vogt-Koyanagi-Harada Disease.
Concha-Del Río LE; Gómez L; Arellanes-García L
Arch Soc Esp Oftalmol (Engl Ed); 2018 May; 93(5):225-230. PubMed ID: 29258782
[TBL] [Abstract][Full Text] [Related]
14. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
16. Clinical Presentation, Management, and Long-Term Outcome of Pars Planitis, Panuveitis, and Vogt-Koyanagi-Harada Disease in Children and Adolescents.
Reiff A
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1589-1596. PubMed ID: 31444859
[TBL] [Abstract][Full Text] [Related]
17. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Yang P; Ye Z; Du L; Zhou Q; Qi J; Liang L; Wu L; Wang C; Kijlstra A
Curr Eye Res; 2018 Feb; 43(2):254-261. PubMed ID: 29111815
[TBL] [Abstract][Full Text] [Related]
18. Reversal of Peripheral Iris Depigmentation Associated with Vogt-Koyanagi-Harada Disease.
Tobaigy MF; AlBloushi AF; Al-Dhibi HA
Ocul Immunol Inflamm; 2024 May; 32(4):424-428. PubMed ID: 36657743
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
[No Abstract] [Full Text] [Related]
20. Vogt-Koyanagi-Harada Syndrome: A Rare Cause of Panuveitis Presenting as Unilateral Loss of Visual Acuity.
Austin D; Moore JS; Gangaputra S
J Clin Rheumatol; 2021 Dec; 27(8S):S838-S839. PubMed ID: 32091452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
